PCM
AVNS icon

Polymer Capital Management’s Avanos Medical AVNS Stock Holding History

Polymer Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,875
Closed -$133K – 763
2025
Q2 		$133K Sell
10,875
-19,355
-64% -$243K 0.02% 572
2025
Q1 		$433K Buy
+30,230
New +$472K 0.11% 244

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Polymer Capital Management's AVNS Position: Q3 2025 in Review

Polymer Capital Management sold out of Avanos Medical (AVNS) in Q3 2025, closing a stake of 10,875 shares — an estimated $133K sold.

Polymer Capital Management first reported a position in AVNS in Q1 2025 and held it in 2 quarters. The position peaked at $433K in Q1 2025. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.

  • Polymer Capital Management reported no remaining Avanos Medical position as of Q3 2025 after selling out during the quarter.
  • Polymer Capital Management sold 10,875 Avanos Medical shares in Q3 2025, an estimated $133K.
  • Polymer Capital Management first reported a position in Avanos Medical in Q1 2025 and held it in 2 quarters.
  • Polymer Capital Management's Avanos Medical position peaked at $433K in Q1 2025.
  • 276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.

Based on Polymer Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.